Xiaobin Wu $BGNE SEC Form 4 Insider Trading

Xiaobin Wu has filed a total of 71 insider trades in $BGNE since 2021. Their most recent trade was a sale of 3,159 shares, made on Feb 18, 2025. Their largest trade was a sale of 21,267 shares, made on Feb 20, 2025. We estimate that they now own shares of $BGNE, worth an estimated $0.

Insider Trading at $BGNE

There have been a total of 568 insider trades reported at $BGNE since 2021, with 165,529 shares purchased and 25.8 million shares sold. The most active insider traders in $BGNE stock have been John Oyler, Xiaobin Wu, and Jane Huang. The most recent trade was a sale of 575 shares reported by Lai Wang (Global Head of R&D), made on Feb 21, 2025.

$BGNE Executives and Stock Owners with Insider Trades

• John Oyler, Chief Executive Officer

• Xiaobin Wu, President, COO & GM China

• Jane Huang, CMO, Hematology

• Lai Wang, Global Head of R&D

• Julia Aijun Wang, Chief Financial Officer

• Chan Henry Lee, SVP, General Counsel

• Howard Liang, CFO & Chief Strategy Officer

• Titus B. Ball, Principal Accounting Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.